Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 369-377

  Kielczewska, Agnieszka ^a   Kim, Hee Seo ^a   Lanier, Lewis L ^b   Dimasi, Nazzareno ^c   Vidal, Silvia M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOPROTEIN; HOMODIMER; IMMUNOGLOBULIN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; PROTEIN; PROTEIN M157; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; C57BL MOUSE; CELL FUNCTION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOMEGALOVIRUS; DIMERIZATION; EMBRYO; FUNCTIONAL PROTEOMICS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KILLER CELL; MOLECULAR MODEL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BLOCKING; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; STRUCTURAL PROTEOMICS; VIRUS INFECTION; WILD TYPE;

EID: 33845935794     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.369     Document Type: Article

References (51)

1. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17: 189-220.
2. Sambhara, S., I. Switzer, A. Kurichh, R. Miranda, L. Urbanczyk, O. James, B. Underdown, M. Klein, and D. Burt. 1998. Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice. Cell. Immunol. 187: 13-18.
3. Shellam, G. R., J. E. Allan, J. M. Papadimitriou, and G. J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA 78: 5104-5108.
4. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
5. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
6. + NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-γ secretion. J. Immunol. 164: 603-611.
7. Brown, M. G., A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
8. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
9. Desrosiers, M. P., A. Kielczewska, J. C. Loredo-Osti, S. G. Adam, A. P. Makrigiannis, S. Lemieux, T. Pham, M. B. Lodoen, K. Morgan, L. L. Lanier, and S. M. Vidal. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37: 593-599.
10. Lee, S. H., S. Girard, D. Macina, M. Busa, A. Zafer, A. Belouchi, P. Gros, and S. M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28: 42-45.
11. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
12. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
13. Gosselin, P., L. H. Mason, J. Willette-Brown, J. R. Ortaldo, D. W. McVicar, and S. K. Anderson. 1999. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J. Leukocyte Biol. 66: 165-171.
14. Sjolin, H., E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195: 825-834.
15. Voigt, V., C. A. Forbes, J. N. Tonkin, M. A. Degli-Esposti, H. R. Smith, W. M. Yokoyama, and A. A. Scalzo. 2003. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. USA 100: 13483-13488.
16. McQueen, K. L., J. D. Freeman, F. Takei, and D. L. Mager. 1998. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics 48: 174-183.
17. bi-Rached, L., and P. Parham. 2005. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 201: 1319-1332.
18. Yokoyama, W. M., and B. F. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3: 304-316.
19. Delano, M. L., and D. G. Brownstein. 1995. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 69: 5875-5877.
20. Pereira, R. A., A. Scalzo, and A. Simmons. 2001. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J. Immunol. 166: 5869-5873.
21. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631.
22. Dimasi, N., M. W. Sawicki, L. A. Reineck, Y. Li, K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 2002. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. J. Mol. Biol. 320: 573-585.
23. Dam, J., R. Guan, K. Natarajan, N. Dimasi, L. K. Chlewicki, D. M. Kranz, P. Schuck, D. H. Margulies, and R. A. Mariuzza. 2003. Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat. Immunol. 4: 1213-1222.
24. Anderson, S. K., J. R. Ortaldo, and D. W. McVicar. 2001. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181: 79-89.
25. Smith, K. M., J. Wu, A. B. Bakker, J. H. Phillips, and L. L. Lanier. 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161: 7-10.
26. Hanke, T., H. Takizawa, C. W. McMahon, D. H. Busch, E. G. Pamer, J. D. Miller, J. D. Altman, Y. Liu, D. Cado, F. A. Lemonnier, et al. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11: 67-77.
27. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166: 5034-5043.
28. Makrigiannis, A. P., J. Etzler, R. Winkler-Pickett, A. Mason, J. R. Ortaldo, and S. K. Anderson, 2000. Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J. Leukocyte Biol. 68: 765-771.
29. Dimasi, N., and R. Biassoni. 2005. Structural and functional aspects of the Ly49 natural killer cell receptors. Immunol. Cell Biol. 83: 1-8.
30. Kane, K. P., E. T. Silver, and B. Hazes. 2001. Specificity and function of activating Ly-49 receptors. Immunol. Rev. 181: 104-114.
31. Natarajan, K., A. Hicks, J. Mans, H. Robinson, R. Guan, R. A. Mariuzza, and D. H. Margulies. 2006. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J. Mol. Biol. 358: 157-171.
32. Bakker, A. B., E. Baker, G. R. Sutherland, J. H. Phillips, and L. L. Lanier. 1999. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl. Acad. Sci. USA 96: 9792-9796.
33. Lee, S. H., A. Zafer, Y. de Repentigny, R. Kothary, M. L. Tremblay, P. Gros, P. Duplay, J. R. Webb, and S. M. Vidal. 2003. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197: 515-526.
34. Kitamura, T. 1998. New experimental approaches in retrovirus-mediated expression screening. Int. J. Hematol. 67: 351-359.
35. Sali, A., and T. L. Blundell. 1993. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234: 779-815.
36. Aloy, P., and R. B. Russell. 2003. InterPreTS: protein interaction prediction through tertiary structure. Bioinformatics 19: 161-162.
37. Hardy, B. J., S. W. Doughty, M. F. Parretti, W. G. Richards, and J. Tennison. 1997. First molecular graphics and modelling society electronic conference. J. Mol. Graph. Model. 15: 141-144.
38. Merritt, E. A., and D. J. Bacon. 1997. Raster 3D: photorealistic molecular graphics. Methods Enzymol. 277: 505-525.
39. DeLano, W. L. 2002. The PyMOL User's Manual. DeLano Scientific, San Carlos, CA.
40. Lian, R. H., Y. Li, S. Kubota, D. L. Mager, and F. Takei. 1999. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues. J. Immunol. 162:7271-7276.
41. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
42. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
43. Kane, K. P., K. J. Lavender, and B. J. Ma. 2004. Ly-49 receptors and their functions. Crit Rev. Immunol. 24: 321-348.
44. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
45. Martin, M. P., and M. Carrington. 2005. Immunogenetics of viral infections. Curr. Opin. Immunol. 17: 510-516.
46. Li, P., D. L. Morris, B. E. Willcox, A. Steinle, T. Spies, and R. K. Strong. 2001. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol 2: 443-451.
47. Li, P., G. McDermott, and R. K. Strong. 2002. Crystal structures of RAE-10 and its complex with the activating immunoreceptor NKG2D. Immunity 16: 77-86.
48. Radaev, S., B. Rostro, A. G. Brooks, M. Colonna, and P. D. Sun. 2001. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15: 1039-1049.
49. Sundback, J., A. Achour, J. Michaelsson, H. Lindstrom, and K. Karre. 2002. NK cell inhibitory receptor Ly-49C residues involved in MHC class I binding. J. Immunol. 168: 793-800.
50. Weis, W. I., R. Kahn, R. Fourme, K. Drickamer, and W. A. Hendrickson. 1991. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. Science 254: 1608-1615.
51. McRee, D. E. 1999. XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125: 156-165.